Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gamze İnan Demiroğlu
The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Dıabetes Mellitus Patients
Turkish Journal of Pharmaceutical Sciences
Molecular Medicine
Pharmaceutical Science
Related publications
Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus
Frontiers in Pharmacology
Pharmacology
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
European Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Role of Dipeptidyl Peptidase-4 Inhibitor in the Control of Glycemic State in Type I and Type II Diabetes Mellitus in Rats: A Comparative Study
The Medical Journal of Cairo University
Dipeptidyl Peptidase-4 (DPP-4; CD26)
Science-Business eXchange
Pharmacokinetic and Pharmacodynamic Interactions Between Metformin and a Novel Dipeptidyl Peptidase-4 Inhibitor, Evogliptin, in Healthy Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science